Bird & Bird secures patent win against SKB for client Synthon
Bird & Bird has won a major House of Lords victory for Dutch pharmaceutical company Synthon against SmithKline Beecham (SKB) (now GlaxoSmithKline). The case concerned the validity of a patent for the compound paroxetine mesylate, which incorporates the active ingredient for one of the world’s most widely prescribed antidepressant drugs. On 20 October, the Lords […]